Moderna Covid vaccine efficacy falls slightly to 90% in US trial

A company press release did not indicate why efficacy has fallen, but one reason might be the emergence of new variants of concern which are not as susceptible to antibodies evoked to the vaccine.

from News-Economic Times https://ift.tt/3a5UUNp